ZoharSachsMD

Oncology • Minneapolis, MN

Hematologic Oncology

Physician

Join to view full profile

Dr. Sachs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sachs' full profile

Already have an account?

Office
420 Delaware St Se
Univ Of Mn Dept Of Medicine 14-154 Moos Mmc 286
Minneapolis, MN 55455
Phone+1 612-626-7055

Fax+1 612-625-6919

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 2008 - 2012
St Elizabeth's Medical CenterResidency, Internal Medicine, 2005 - 2008
Tufts University School of MedicineClass of 2005

Certifications & Licensure

MN State Medical License 2008 - 2025
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Patients with-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution...
Nuttavut Sumransub, Gabriel K Steinwand, Keith Cordner, Yoonkyu Lee, Qing Cao
Cancers. 2024-08-07
2 citations
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis.
Yoonkyu Lee, Linda B Baughn, Chad L Myers, Zohar Sachs
Blood Cancer Journal. 2024-05-14
4 citations
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
Zhiyan Silvia Liu, Sayantani Sinha, Maxwell Bannister, Axia Song, Erica Arriaga-Gomez
Cancer Research. 2024-02-15

Abstracts/Posters

High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+3
Zohar Sachs, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Cell Type-Specific Effects of Crizotinib in Human Acute Myeloid Leukemia with TP53 Alterations
Zohar Sachs, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019